health · HHS-NIH11
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-040
Deadline
September 7, 2026
GRANTQUICK SUMMARYPlain-English Overview
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional). National Institutes of Health. Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to... Funding amounts not specified.
Who Should Apply
For-profit organizations, County governments, Small businesses, Nonprofits (non-501c3), Private universities/colleges (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
- •Deadline: 2026-09-07
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
NIH Grants Information grantsinfo@nih.gov
grantsinfo@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov